Emergent BioSolutions (NYSE: EBS) announced that it has signed a strategic long-term manufacturing agreement with ProMetic Life Sciences Inc. This agreement provides ProMetic access to Emergent’s cGMP FDA-licensed biopharmaceuticals facility located in Winnipeg, Manitoba, Canada.
{iframe}http://www.streetinsider.com/Corporate+News/Emergent+BioSolutions+(EBS),+ProMetic+Life+Sciences+Enter+Agreement+Covering+cGMP+Facility/10575887.html{/iframe}